Nutrition Last reviewed: June 30, 2026

Does potassium intake lower blood pressure?

Strong Evidence
Confidence Score 76%

YES

Strong evidence from multiple meta-analyses confirms that increased potassium intake lowers blood pressure, particularly in hypertensive individuals consuming high-sodium diets. WHO-endorsed findings support population-level recommendations.

The Verdict

Strong evidence from multiple meta-analyses confirms that increased potassium intake lowers blood pressure, particularly in hypertensive individuals consuming high-sodium diets. WHO-endorsed findings support population-level recommendations.

What the Evidence Shows

The blood pressure-lowering effect of potassium is supported by decades of clinical research and endorsed by the World Health Organization. A landmark 2013 BMJ meta-analysis commissioned by WHO analyzed 22 randomized controlled trials and found that increased potassium intake reduced systolic blood pressure by 3.49 mmHg and diastolic by 1.96 mmHg in adults, with larger effects in hypertensive individuals (systolic reduction of 5.32 mmHg). These findings confirmed earlier meta-analytic work from 1997 in JAMA that reported similar magnitudes. A 2020 meta-analysis further validated the dose-response relationship. The mechanism is well-understood: potassium promotes natriuresis (sodium excretion through urine), relaxes vascular smooth muscle, reduces sympathetic nervous system activity, and modulates the renin-angiotensin-aldosterone system. The potassium-to-sodium ratio appears more important than absolute potassium intake, explaining why benefits are most pronounced in populations consuming high-sodium diets. Dietary sources (fruits, vegetables, legumes) and supplemental potassium both demonstrate efficacy, though food-based approaches provide additional beneficial nutrients. The effect magnitude of 3-5 mmHg systolic reduction is clinically meaningful at the population level, estimated to reduce stroke risk by 8-15%. Current guidelines recommend 3,500-4,700 mg potassium daily, yet most Western populations consume well below this level. The evidence is strongest for individuals with hypertension and those with high sodium intake.

Evidence Quality

4

Meta-Analyses

22

RCTs

15

Observational

Important Caveats

  • ⚠️ Effects are most pronounced in hypertensive individuals and may be minimal in normotensive people
  • ⚠️ High potassium intake is dangerous for those with impaired kidney function
  • ⚠️ Dietary potassium sources may differ in efficacy from supplemental forms
  • ⚠️ The sodium-to-potassium ratio may matter more than potassium alone
  • ⚠️ Individual response varies with genetic factors and baseline dietary patterns

Population Studied

Adults with and without hypertension across diverse populations; strongest evidence in hypertensive adults consuming high-sodium diets

Dosage

WHO recommends at least 3,510 mg/day; meta-analyses show benefits with supplemental doses of 30-120 mmol/day (1,200-4,700 mg/day)

Duration

Blood pressure reductions observed within 4-8 weeks of increased intake; sustained with continued consumption

Supporting Studies (3)

Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses

Meta-Analysis

Aburto NJ, Hanson S, Gutierrez H, et al. · BMJ (2013)

WHO-commissioned meta-analysis of 22 RCTs found increased potassium intake reduced systolic BP by 3.49 mmHg and diastolic by 1.96 mmHg in adults, with 24% reduced stroke risk and no adverse effects on renal function or lipids.

View paper (DOI) →

Potassium intake and blood pressure: a dose-response meta-analysis of randomized controlled trials

Meta-Analysis

Filippini T, Violi F, D'Amico R, Vinceti M. · Journal of the American College of Nutrition (2020)

Dose-response meta-analysis confirmed linear blood pressure reductions with increasing potassium intake, with effects plateauing around 90-120 mmol/day and larger benefits in hypertensive individuals.

View paper (DOI) →

Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials

Meta-Analysis

Whelton PK, He J, Cutler JA, et al. · JAMA (1997)

Meta-analysis of 33 RCTs found potassium supplementation reduced systolic BP by 3.11 mmHg and diastolic by 1.97 mmHg, with larger effects in hypertensive subjects and those with higher sodium intake.

View paper (DOI) →

Contradicting Studies (1)

Potassium supplementation for the management of primary hypertension in adults: a dose-response meta-analysis

Meta-Analysis

Binia A, Jaeger J, Hu Y, Singh A, Zimmermann D. · Journal of Hypertension (2015)

While confirming potassium lowers blood pressure, this analysis found the dose-response curve flattens at moderate doses, and noted that effects in normotensive individuals are clinically negligible, questioning universal supplementation recommendations.

Why this disagrees:

Suggests the benefit is limited to specific subpopulations (hypertensive, high-sodium consumers) and that blanket potassium supplementation for the general population may not produce meaningful blood pressure improvements, particularly in those already normotensive.

View paper (DOI) →
Share:
Was this helpful?

Related Claims